Business
Interim report Q1 2025
Strong start to the year and confirmed full-year outlook Ester Baiget, President & CEO: “We delivered strong sales growth and earnings in the first quarter, with all four sales areas showing double-digit growth. Growth was driven by strong innovation especially in emerging markets, and with a continued broad pull for our solutions in developed markets. Synergies are materializing as expected and we are confirming the full-year outlook. We continue to see solid demand across the business, and our
About this update from Novonesis A/s Class B
[{"type":"image","alt":"Novonesis (Novozymes A/S)","displaySize":"","headline":null,"caption":"Novonesis (Novozymes A/S)","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":38,"url":"https://media.zenfs.com/en/globenewswire.com/d587064c2241c08df4f2bac0e72e38fb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zKklvML9_v1QAJVxEtCwVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/d587064c2241c08df4f2bac0e72e38fb","width":300,"height":38}},"lazy":false},{"type":"text","content":"Strong start to the year and confirmed full-year outlook ","length":56,"tagName":"p"},{"type":"text","content":"Ester Baiget, President & CEO: “We delivered strong sales growth and earnings in the first quarter, with all four sales areas showing double-digit growth. Growth was driven by strong innovation especially in emerging markets, and with a continued broad pull for our solutions in developed markets. Synergies are materializing as expected and we are confirming the full-year outlook. We continue to see solid demand across the business, and our regional presence and resilient global setup enable us to respond with agility in these dynamic times”.","length":557,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Strong organic sales growth of 11% including ~1pp from price. All sales areas with double-digit organic sales growth. Emerging markets organic sales growth at 15% and developed markets at 9%.","length":191,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA margin at 38.3%, up by 310bps.","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted net profit increased by 27%.","length":37,"tagName":"p"}]},{"val":[{"type":"text","content":"NIBD/EBITDA at 1.1x.","length":20,"tagName":"p"}]},{"val":[{"type":"text","content":"Announcement on February 11 to acquire dsm-firmenich’s part of the feed enzyme alliance at a EUR 1.5bn cash consideration, expected to close in the second quarter.","length":163,"tagName":"p"}]},{"val":[{"type":"text","content":"Andrew Taylor announced on April 22 as new EVP Food & Beverages, joining the company no later than September 1, 2025.","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"2025 outlook maintained: 5-8% organic sales growth (6-9% excluding the exit from certain countries) an...